RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
D.Western Therapeutics Institute Stock

D.Western Therapeutics Institute Employees 2025

D.Western Therapeutics Institute Employees

17

Ticker

4576.T

ISIN

JP3548740004

WKN

A0YB73

In 2025, D.Western Therapeutics Institute employed 17 people, a 0% change from the 17 number of employees in the previous year.

D.Western Therapeutics Institute Aktienanalyse

What does D.Western Therapeutics Institute do?

D. Western Therapeutics Institute Inc is an American company specializing in the development and marketing of innovative therapies. The company is headquartered in Los Angeles, California and has continuously grown since its founding in 2005. Its goal is to develop novel therapies that provide increased effectiveness and safety to treat chronic diseases and improve patients' lives. In its early years, the company focused on researching and developing therapies for autoimmune diseases such as Rheumatoid Arthritis and Lupus. Over the years, the company has expanded its portfolio and also focused on researching cancer therapies and developing medications for rare diseases. D. Western Therapeutics Institute Inc's business model is designed to develop innovative therapies and bring them to market. The company relies on a combination of its own research and development, as well as collaborations with other companies and research institutions. Another important aspect of its business model is creating partnerships with healthcare facilities and payers to ensure that the therapies are accessible to patients within their respective healthcare systems. The company is divided into different divisions to coordinate the research and development of therapies for different diseases. Each division works independently to ensure that the company can focus on the specific needs of each patient group. For autoimmune diseases, the company focuses on developing therapies for Rheumatoid Arthritis, Lupus, Multiple Sclerosis, and Psoriasis. These therapies aim to modulate the immune system and reduce inflammatory reactions. In the cancer division, the company focuses on developing therapies for various types of cancer such as kidney cancer, breast cancer, and leukemia. The company relies on innovative approaches, such as developing personalized therapies tailored to individual patients. D. Western Therapeutics Institute Inc also develops therapies for rare diseases that are often difficult to treat. The company works closely with patient groups and healthcare facilities to ensure that the therapies meet the needs of patients. The company has a variety of products in development and on the market, targeting the needs of patients in various areas of medicine. Some products are already on the market, while others are still in research and development. One of the products already on the market is a novel medication for the treatment of Rheumatoid Arthritis developed based on biotherapeutics. The medication aims to modulate the immune system and reduce the inflammatory reactions associated with the disease. Another product already on the market is a novel medication for the treatment of kidney cancer. The medication is based on a combination of chemotherapy and immunotherapy, targeting the tumor cells specifically. In conclusion, D. Western Therapeutics Institute Inc is an innovative company specializing in the development of novel therapies. The company relies on a combination of its own research and development, as well as collaborations with other companies and research institutions. With its focus on different divisions and collaboration with patient groups and healthcare facilities, the company aims to develop therapies that meet the needs of patients and improve their quality of life. D.Western Therapeutics Institute ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining D.Western Therapeutics Institute's Employee Base

D.Western Therapeutics Institute's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding D.Western Therapeutics Institute's operational capacity and future potential.

Year-to-Year Comparison

Assessing D.Western Therapeutics Institute's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

D.Western Therapeutics Institute's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in D.Western Therapeutics Institute’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about D.Western Therapeutics Institute stock

How many employees does D.Western Therapeutics Institute have this year?

D.Western Therapeutics Institute has 17 undefined employees this year.

How many employees did D.Western Therapeutics Institute have compared to the previous year?

Compared to the previous year, D.Western Therapeutics Institute had 0% more employees.

What impact did the number of employees have on the company D.Western Therapeutics Institute?

The number of employees has a direct impact on the efficiency and productivity of D.Western Therapeutics Institute. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of D.Western Therapeutics Institute?

The number of employees can also have an impact on investors of D.Western Therapeutics Institute, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of D.Western Therapeutics Institute affect the company?

An increase in equity of D.Western Therapeutics Institute can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in D.Western Therapeutics Institute's equity affect the company?

A reduction in equity of D.Western Therapeutics Institute can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of D.Western Therapeutics Institute?

Some factors that can influence the equity of D.Western Therapeutics Institute include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of D.Western Therapeutics Institute so important for investors?

The equity of D.Western Therapeutics Institute is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at D.Western Therapeutics Institute influence the company?

The number of employees at D.Western Therapeutics Institute can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at D.Western Therapeutics Institute evolved in recent years?

In recent years, the number of employees at D.Western Therapeutics Institute has changed by 0.

How many employees does D.Western Therapeutics Institute currently have?

D.Western Therapeutics Institute currently has 17 undefined employees.

Why is the number of employees important for investors of D.Western Therapeutics Institute?

The number of employees is important for investors of D.Western Therapeutics Institute as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can D.Western Therapeutics Institute take to change the number of employees?

To change the number of employees, D.Western Therapeutics Institute can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does D.Western Therapeutics Institute pay?

Over the past 12 months, D.Western Therapeutics Institute paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, D.Western Therapeutics Institute is expected to pay a dividend of 0 JPY.

What is the dividend yield of D.Western Therapeutics Institute?

The current dividend yield of D.Western Therapeutics Institute is .

When does D.Western Therapeutics Institute pay dividends?

D.Western Therapeutics Institute pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of D.Western Therapeutics Institute?

D.Western Therapeutics Institute paid dividends every year for the past 0 years.

What is the dividend of D.Western Therapeutics Institute?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is D.Western Therapeutics Institute located?

D.Western Therapeutics Institute is assigned to the 'Health' sector.

Wann musste ich die Aktien von D.Western Therapeutics Institute kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of D.Western Therapeutics Institute from 8/10/2025 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 8/10/2025.

When did D.Western Therapeutics Institute pay the last dividend?

The last dividend was paid out on 8/10/2025.

What was the dividend of D.Western Therapeutics Institute in the year 2024?

In the year 2024, D.Western Therapeutics Institute distributed 0 JPY as dividends.

In which currency does D.Western Therapeutics Institute pay out the dividend?

The dividends of D.Western Therapeutics Institute are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von D.Western Therapeutics Institute

Our stock analysis for D.Western Therapeutics Institute Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of D.Western Therapeutics Institute Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.